Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [21] Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma
    Stoker, Sharon D.
    Novalic, Zlata
    Wildeman, Maarten A.
    Huitema, Alwin D. R.
    Verkuijlen, Sandra A. W. M.
    Juwana, Hedy
    Greijer, Astrid E.
    Tan, I. Bing
    Middeldorp, Jaap M.
    de Boer, Jan Paul
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1845 - 1857
  • [22] Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma
    Yu, Fenggang
    Lu, Yanan
    Petersson, Fredrik
    Wang, De-Yun
    Loh, Kwok Seng
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (07): : 1515 - 1523
  • [23] Genomic landscape of Epstein-Barr virus in familial nasopharyngeal carcinoma
    Zhang, Wen-Li
    Zhang, Jiang-Bo
    Wang, Tong-Min
    Wu, Yan-Xia
    He, Yong-Qiao
    Xue, Wen-Qiong
    Liao, Ying
    Deng, Chang-Mi
    Li, Dan-Hua
    Wu, Zi-Yi
    Yang, Da-Wei
    Zheng, Xiao-Hui
    Li, Xi-Zhao
    Zhou, Ting
    Zhang, Pei-Fen
    Zhang, Shao-Dan
    Hu, Ye-Zhu
    Jia, Wei-Hua
    JOURNAL OF GENERAL VIROLOGY, 2022, 103 (03)
  • [24] The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients
    Matalka, Ismail
    Al Hamad, Mohammad
    Al-Hussaini, Maysa
    Alzoubi, Firas Q.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (01) : 229 - 234
  • [25] Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection
    Peng, Xintong
    Zhou, Yanling
    Tao, Yongguang
    Liu, Shuang
    PATHOGENS, 2021, 10 (09):
  • [26] Association of Epstein-Barr virus and nasopharyngeal carcinoma in caucasian patients
    Plaza, G
    Manzanal, AI
    Fogué, L
    Santón, A
    Martínez-Montero, JC
    Bellas, C
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2002, 111 (03) : 210 - 216
  • [27] Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA
    Wei, Zhi-Gong
    Hu, Xiao-Lin
    He, Yan
    Guan, Hui
    Wang, Jing-Jing
    He, Ling
    Mu, Xiao-Li
    Liu, Zhe-Ran
    Li, Rui-Dan
    Peng, Xing-Chen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (05): : 1465 - 1475
  • [28] Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA
    Yao, Ji-Jin
    Lin, Li
    Jin, Ya-Nan
    Wang, Si-Yang
    Zhang, Wang-Jian
    Zhang, Fan
    Zhou, Guan-Qun
    Cheng, Zhi-Bin
    Qi, Zhen-Yu
    Sun, Ying
    CANCER SCIENCE, 2017, 108 (08) : 1640 - 1646
  • [29] Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy
    Pow, Edmond H. N.
    Law, Mike Y. T.
    Tsang, Peter C. S.
    Perera, Ranawaka A. P. M.
    Kwong, Dora L. W.
    ORAL ONCOLOGY, 2011, 47 (09) : 879 - 882
  • [30] Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma
    Tang, Julian W.
    Rohwaeder, Edda
    Chu, Ida M. T.
    Tsang, Raymond K. Y.
    Steinhagen, Katja
    Yeung, Apple. C. M.
    To, K. F.
    Chan, Paul K. S.
    JOURNAL OF CLINICAL VIROLOGY, 2007, 40 (04) : 284 - 288